DE69208913D1 - 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung - Google Patents

2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung

Info

Publication number
DE69208913D1
DE69208913D1 DE69208913T DE69208913T DE69208913D1 DE 69208913 D1 DE69208913 D1 DE 69208913D1 DE 69208913 T DE69208913 T DE 69208913T DE 69208913 T DE69208913 T DE 69208913T DE 69208913 D1 DE69208913 D1 DE 69208913D1
Authority
DE
Germany
Prior art keywords
oxindole
rectal administration
carboxamide derivative
medicament containing
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69208913T
Other languages
English (en)
Other versions
DE69208913T2 (de
Inventor
Walter Fries
Guenther Dr Pfaff
Carl Joerg Pfitzner
Gerhard Dr Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MACK CHEM PHARM
Original Assignee
MACK CHEM PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MACK CHEM PHARM filed Critical MACK CHEM PHARM
Priority to DE69208913T priority Critical patent/DE69208913T2/de
Publication of DE69208913D1 publication Critical patent/DE69208913D1/de
Application granted granted Critical
Publication of DE69208913T2 publication Critical patent/DE69208913T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE69208913T 1991-04-08 1992-04-02 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung Expired - Fee Related DE69208913T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69208913T DE69208913T2 (de) 1991-04-08 1992-04-02 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4111305A DE4111305C2 (de) 1991-04-08 1991-04-08 Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE69208913T DE69208913T2 (de) 1991-04-08 1992-04-02 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung

Publications (2)

Publication Number Publication Date
DE69208913D1 true DE69208913D1 (de) 1996-04-18
DE69208913T2 DE69208913T2 (de) 1996-07-25

Family

ID=6429051

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4111305A Expired - Fee Related DE4111305C2 (de) 1991-04-08 1991-04-08 Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE69208913T Expired - Fee Related DE69208913T2 (de) 1991-04-08 1992-04-02 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4111305A Expired - Fee Related DE4111305C2 (de) 1991-04-08 1991-04-08 Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält

Country Status (7)

Country Link
EP (1) EP0508310B1 (de)
JP (1) JPH05112527A (de)
AT (1) ATE135210T1 (de)
DE (2) DE4111305C2 (de)
DK (1) DK0508310T3 (de)
ES (1) ES2084204T3 (de)
GR (1) GR3019968T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
CN1116822A (zh) * 1993-01-22 1996-02-14 美国辉瑞有限公司 6-氯-5-氟-3-(2-噻吩甲酰)-2-羟吲哚-1-羰酰胺的赖氨酸盐

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Also Published As

Publication number Publication date
DE4111305A1 (de) 1992-10-15
EP0508310B1 (de) 1996-03-13
ATE135210T1 (de) 1996-03-15
EP0508310A1 (de) 1992-10-14
DE4111305C2 (de) 1994-12-01
ES2084204T3 (es) 1996-05-01
DK0508310T3 (da) 1996-06-10
GR3019968T3 (en) 1996-08-31
JPH05112527A (ja) 1993-05-07
DE69208913T2 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
FI933248A (fi) Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
ATE84413T1 (de) Arzneimittel, enthaltend di-tert.butylhydroxyphenyl-derivatesowie neue derivate.
IL104158A0 (en) Bicyclotridecenone compounds,their preparation and pharmaceutical compositions containing them
FI933477A0 (fi) Monohydrat av ett dinatriumsalt av 4-klorfenyltiometylenbisfosfonsyra,dess framstaellning och farmaceutiska kompositioner innehaollande detta
DE69208913D1 (de) 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE69206460T2 (de) Injizierbare 2-Oxindol-1-carboxamidderivate enthaltende Arzneizubereitungen.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
ATE145824T1 (de) Aerosolformulierung enthaltend fusafungin
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
ES2141228T3 (es) Derivados del benzopirano.
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
FI924939A0 (fi) Nya kinoloner, foerfarande foer framstaellning daerav och farmaceutiska kompositioner innehaollande dessa
IT1254632B (it) Uso di acido iodesossicolico come promotore di assorbimento di farmaci
MX9206975A (es) Composicion farmaceutica.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
ATE307577T1 (de) Pharmazeutische zusammensetzungen enthaltend neue iso-butenyl-substituierte taxane

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee